Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings

  1. Castañon, E.
  2. Sanchez-Arraez, A.
  3. Alvarez-Manceñido, F.
  4. Jimenez-Fonseca, P.
  5. Carmona-Bayonas, A.
Aldizkaria:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Argitalpen urtea: 2020

Alea: 136

Orrialdeak: 159-168

Mota: Artikulua

DOI: 10.1016/J.EJCA.2020.06.003 GOOGLE SCHOLAR
Datuen iturria: Scopus